Drug results: 2
fluvoxamine | A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS. Because of its high affinity at the sigma-1 receptor, the drug was evaluated whether could prevent clinical deterioration in patients with COVID-19. At the moment, there are insufficient data to recommend either for or against use of fluvoxamine for the treatment of COVID-19. | |
pirfenidone | pyridone, indicated for the treatment of idiopathic pulmonary fibrosis |
Citing DrugCentral © 2024. License